PUBLISHER: Grand View Research | PRODUCT CODE: 1553446
PUBLISHER: Grand View Research | PRODUCT CODE: 1553446
The global hysteroscopy instruments market size is expected to reach USD 3.04 billion by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing preference for minimally invasive procedures is anticipated to foster the hysteroscopy instruments market growth during the forecast period. There is a shift towards minimally invasive procedures due to their advantages, such as reduced recovery time, lower risk of infection, and less post-operative pain compared to traditional surgeries. According to a study published in the Journal of Minimally Invasive Gynecology, minimally invasive hysteroscopic procedures lead to faster recovery and lower complication rates, which enhances patient satisfaction.
The prevalence of gynecological conditions such as abnormal uterine bleeding, endometrial polyps, fibroids, and pelvic pain is increasing. These conditions often require hysteroscopic evaluation or treatment. According to the American College of Obstetricians and Gynecologists (ACOG), up to 25% of women experience abnormal uterine bleeding at some point. Conditions such as uterine fibroids affect 20-50% of women during their reproductive years.
Advances such as high-definition (HD) cameras, flexible scopes, miniaturized instruments, and improved light sources have significantly enhanced the quality and precision of hysteroscopic procedures. Modern hysteroscopes offer better visualization and more precise diagnostics. For instance, HD scopes provide clearer images, reducing the likelihood of diagnostic errors and improving procedural outcomes.